BioNTech SE (BNTX) Other financing activities (2019 - 2025)
BioNTech SE (BNTX) reported Other financing activities of -$13.4 million for Q3 2025, down 54.96% on a YoY basis from -$29.8 million in Q3 2024, and up 10.7% sequentially from -$15.1 million in Q2 2025.
BioNTech SE (BNTX) Other financing activities (2019 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 7 years of Other financing activities data on file, last reported at -$13.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.44 Mn |
| Sep 30, 2025 | -13.44 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Jun 30, 2022 | -833.90 Mn |
| Jun 30, 2022 | -833.90 Mn |